Professor of Pharmaceutical Sciences, Associate Dean of Graduate Studies, School of Pharmacy
Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo
Buffalo, New York, United States
Dr. Bies is currently Professor of Pharmaceutical Sciences and Associate Dean for Graduate Education at the School of Pharmacy and Pharmaceutical Sciences as well as a member of the Institute for Artificial Intelligence and Data Science at the State University of New York at Buffalo. Prior to this, Dr. Bies was Associate Professor of Medicine and Medical and Molecular Genetics at the Indiana University School of Medicine and Director of the Disease and Therapeutic Response Modeling program for the Indiana Clinical Translational Sciences Institute. He serves as: project scientist at CAMH, University of Toronto; on the editorial boards of the Journal of Pharmacokinetics and Pharmacodynamics, Clinical Pharmacology and Therapeutics:Pharmacometrics and Systems Pharmacology, Biopharmaceutics and Drug Disposition; and the British Journal of Clinical Pharmacology. Dr. Bies is a member of ISoP, ACCP and ASCPT. He is also a Fellow of the International Society for Pharmacometrics.
.
Dr. Bies received a BSc degree in Pharmacy from the University of Toronto (1991), a Pharm.D. from the UTHSCSA and the University of Texas at Austin (1994) and a Ph.D. Pharmacology from Georgetown University in 1998. This was followed by postdoctoral training at the Center for Drug Development Sciences until 2000.
His research focuses on the application of pharmacometric approaches in HIV, opiate addiction, pediatrics, psychiatry, oncology and neurology as well as on novel methods development including machine learning approaches to model selection and optimization methods for parameter optimization in dynamic systems.
Disclosure(s): Advanced Bioscience Laboratories NIAID: Consultant/Advisory Board (Ongoing)
Tuesday, November 12, 2024
2:00 PM – 3:30 PM MST
User-Friendly Tools for Population PK and PBPK Modeling
Tuesday, November 12, 2024
2:00 PM – 2:30 PM MST